Yanyan Qu Department of Medicine University of Pittsburgh Biography Publications Institution JoVE Articles Yanyan Qu has not added a biography. If you are Yanyan Qu and would like to personalize this page please email our Author Liaison for assistance. Publications Thrombospondin-1 Protects Against Pathogen-induced Lung Injury by Limiting Extracellular Matrix Proteolysis JCI Insight. Feb, 2018 | Pubmed ID: 29415890 A -Specific TCR-Transgenic Mouse Demonstrates Th1 Polyfunctionality with Enhanced Effector Function Journal of Immunology (Baltimore, Md. : 1950). 10, 2017 | Pubmed ID: 28855311 Patient-Derived Airway Secretion Dissociation Technique To Isolate and Concentrate Immune Cells Using Closed-Loop Inertial Microfluidics Analytical Chemistry. May, 2017 | Pubmed ID: 28402103 CD36 Provides Host Protection Against Klebsiella Pneumoniae Intrapulmonary Infection by Enhancing Lipopolysaccharide Responsiveness and Macrophage Phagocytosis The Journal of Infectious Diseases. Dec, 2016 | Pubmed ID: 27683817 Comparable Genital Tract Infection, Pathology, and Immunity in Rhesus Macaques Inoculated with Wild-Type or Plasmid-Deficient Chlamydia Trachomatis Serovar D Infection and Immunity. Oct, 2015 | Pubmed ID: 26216426 Extranodal Induction of Therapeutic Immunity in the Tumor Microenvironment After Intratumoral Delivery of Tbet Gene-modified Dendritic Cells Cancer Gene Therapy. Aug, 2013 | Pubmed ID: 23846252 Combined Tbet and IL12 Gene Therapy Elicits and Recruits Superior Antitumor Immunity in Vivo Molecular Therapy : the Journal of the American Society of Gene Therapy. Mar, 2012 | Pubmed ID: 22215017 Therapeutic Effectiveness of Intratumorally Delivered Dendritic Cells Engineered to Express the Pro-inflammatory Cytokine, Interleukin (IL)-32 Cancer Gene Therapy. Sep, 2011 | Pubmed ID: 21760628 Intralesional Delivery of Dendritic Cells Engineered to Express T-bet Promotes Protective Type 1 Immunity and the Normalization of the Tumor Microenvironment Journal of Immunology (Baltimore, Md. : 1950). Sep, 2010 | Pubmed ID: 20675595 IL-4 Suppresses Very Late Antigen-4 Expression Which is Required for Therapeutic Th1 T-cell Trafficking into Tumors Journal of Immunotherapy (Hagerstown, Md. : 1997). Oct, 2009 | Pubmed ID: 19752754 लेबल-रोगी से मुक्त न्युट्रोफिल संवर्धन-व्युत्पन्न Airway स्राव का उपयोग बंद पाश Inertial Microfluidics Hyunryul Ryu1, Kyungyong Choi1,2, Yanyan Qu3, Taehong Kwon1,2, Janet S. Lee3,5, Jongyoon Han1,2,4 1Research Laboratory of Electronics, Massachusetts Institute of Technology, 2Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, 3Department of Medicine, University of Pittsburgh, 4Department of Biological Engineering, Massachusetts Institute of Technology, 5Vascular Medicine Institute, University of Pittsburgh JoVE 57673 Immunologie et Infection
लेबल-रोगी से मुक्त न्युट्रोफिल संवर्धन-व्युत्पन्न Airway स्राव का उपयोग बंद पाश Inertial Microfluidics Hyunryul Ryu1, Kyungyong Choi1,2, Yanyan Qu3, Taehong Kwon1,2, Janet S. Lee3,5, Jongyoon Han1,2,4 1Research Laboratory of Electronics, Massachusetts Institute of Technology, 2Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, 3Department of Medicine, University of Pittsburgh, 4Department of Biological Engineering, Massachusetts Institute of Technology, 5Vascular Medicine Institute, University of Pittsburgh JoVE 57673 Immunologie et Infection